Evidence map›Paper›PMID 29491017›Full record

ArticleJournal of clinical microbiology2018

Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.

Alex-Mikael Barkoff, Jussi Mertsola, Denis Pierard, Tine Dalby, Silje Vermedal Hoegh, Sophie Guillot, Paola Stefanelli, Marjolein van Gent, Guy Berbers, Didrik F Vestrheim and 7 more

Abstract readComparative Study
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic epidemiology and evolution ofEmerging microbes & infections · 2025
    Article
  5. Article
  6. Pertussis vaccines, epidemiology and evolution.Nature reviews. Microbiology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Macrolide Resistance inAntibiotics (Basel, Switzerland) · 2022
    Review
  11. Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Article
  12. Article
  13. Genotypes ofZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2022
    Article
  14. Macrolide susceptibility and molecular characteristics ofThe Journal of international medical research · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alex-Mikael BarkoffDepartment of Medical Microbiology and Immunology, University of Turku, Turku, Finland.
Jussi MertsolaDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland.
Denis PierardDepartment of Microbiology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Tine DalbyStatens Serum Institut, Infectious Disease Preparedness-Bacteria, Parasites and Fungi, Copenhagen, Denmark.
Silje Vermedal HoeghDepartment of Clinical Microbiology, Odense, University Hospital, Odense, Denmark.
Sophie GuillotNational Reference Center of Whooping Cough and Other Bordetelloses, Institut Pasteur, Paris, France.
Paola StefanelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Marjolein van GentCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Guy BerbersCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Didrik F VestrheimDepartment of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Margrethe Greve-IsdahlDepartment of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Lena WehlinDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Margaretha LjungmanDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Norman K FryRespiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England-National Infection Service, London, United Kingdom.ORCID 0000-0003-4862-6507
Kevin MarkeyNational Institute for Biological Standards and Control, Potters Bar, United Kingdom.
Kari AuranenDepartment of Mathematics and Statistics, University of Turku, Turku, Finland.
Qiushui HeDepartment of Medical Microbiology and Immunology, University of Turku, Turku, Finland qiushui.he@utu.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One reason for increased pertussis incidence is the adaptation of

Indexed as

Epidemiological MonitoringBordetella pertussisDNA, BacterialEuropeGenes, BacterialGenetic VariationGenome, BacterialGenotypeHumansMolecular TypingPertussis VaccineSequence Analysis, DNASerogroupSerotypingWhooping CoughDNA, BacterialPertussis VaccineBordetella pertussisEuropegenotypingMLVAPFGEserotyping

Identifiers

PMID29491017
PMCPMC5925733

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.